Biomoda is a cancer diagnostics company focused on the development of an inexpensive, simple, highly accurate in-vitro test for the early detection of lung cancer. The CyPath® assay is based upon Biomoda’s patent estate centered on molecular marker technology originally developed at the Los Alamos National Laboratory.
Biomoda is a cancer diagnostics company focused on the development of an inexpensive, simple, highly accurate in-vitro test for the early detection of lung cancer. The CyPath® assay is based upon Biomoda’s patent estate centered on molecular marker technology originally developed at the Los Alamos National Laboratory.